Qbiotics concludes successful $85 million capital raise
- Written by PR Newswire
- Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners.
- Funding to enable human clinical development of the Company's anticancer drug candidate tigilanol tiglate and its wound healing drug candidate EBC-1013.
BRISBANE, Australia, June 28, 2021 /PRNewswire/ --...
